FFCP PHASE2:Hg19::chr12:6826147..6826153,+
From FANTOM5_SSTAR
Revision as of 11:38, 24 July 2015 by Autoedit (talk | contribs) (Created page with "{{FFCP |DHSsupport=supported |DPIdataset=robust |EntrezGene=NA |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript |HGNC=NA |TSSclassifier=stron...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p@chr12:6826147..6826153, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr12:6826147..6826153, + |
Coexpression cluster: | C19_embryonic_testis_cord_chronic_CD14_NK_mesothelioma |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p@chr12:6826147..6826153+ |
---|
0
50
100
150
200
250
300
350
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 6.02e-42 | 235 |
disease of cellular proliferation | 1.22e-40 | 239 |
hematologic cancer | 1.41e-29 | 51 |
immune system cancer | 1.41e-29 | 51 |
organ system cancer | 5.28e-28 | 137 |
leukemia | 1.77e-22 | 39 |
myeloid leukemia | 1.52e-15 | 31 |
cell type cancer | 4.93e-15 | 143 |
carcinoma | 2.11e-13 | 106 |
chronic leukemia | 1.93e-12 | 8 |
Showing 1 to 10 of 11 entries